Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Oncology Reports
Erschienen in: Current Oncology Reports 9/2020

01.09.2020 | Head and Neck Cancers (EY Hanna, Section Editor)

The Management of rNPC: Salvage Surgery vs. Re-irradiation

verfasst von: Chung-Yu Hao, Sheng-Po Hao

Erschienen in: Current Oncology Reports | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Treatment failure, in the form of either persistence or local recurrence, occurs in 10 to 30% of nasopharyngeal carcinoma patients after initial radiotherapy (RT). Early detection of persistent or recurrent disease aids in the recognition of tumors that can be candidates for salvage nasophayngectomy or re-irradiation. There is no consensus till now on the indications or selection of the above two salvage treatment.

Recent Findings

In recent years, there has been a paradigm shift from open to endoscopic approach for nasopharyngectomy, which carries nearly no complications. For salvage re-irradiation, intensity-modulated radiotherapy (IMRT) is the most commonly indicated modality. Compared to IMRT, salvage endoscopic nasopharyngectomy may be more beneficial in terms of prolonging survival, improving quality of life, and minimizing treatment-related complications and medical costs in a selected subset of recurrent nasopharyngeal carcinoma (rNPC) patients.

Summary

Salvage nasopharyngectomy should be the mainstay of treatment for rNPC.
Literatur
1.
Hao SP. Carcinoma of the Nasopharynx. In: Alper C, Myers E, Eibling D, editors. Decision Making in Otolaryngology, 2nd ed. New Delhi: Jaypee Brothers Medical Publishers; 2019. p. 152–3.
2.
• Yue Q, Zhang M, Chen Y, Zheng D, Chen Y, Feng M. Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: a meta-analysis. Oral Oncol. 2018;81:81–8 This mete-analysis article on IMRT reports recurrent T stage and tumor volume may serve as prognosis factors for overall survival in rNPC. CrossRef
3.
Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;83(2):676–83.CrossRef
4.
• Ho JC, Phan J. Reirradiation of head and neck cancer using modern highly conformal techniques. Head Neck. 2018;40:2078–93 This article reports that IMRT, proton therapy, and stereotactic RT are feasible treatment options for rNPC. CrossRef
5.
• Lee A, Ng WT, Chan J. Management of locally recurrent nasopharyngealcarcinoma. Cancer Treat Rev. 2019;79:101890 In this review article, the authors report the importance of early detection of recurrence for possible salvage. The rationale behind the recurrence can be radio-resistance. CrossRef
6.
Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, et al. Quantification of plasma Epstein–Barr virus DNA in patients with advanced nasopharyngeal carcinoma. NEJM. 2004;350:2461–70.CrossRef
7.
Tsang NM, Chuang CC, Tseng CK, Hao SP, Kuo TT, Lin CY, et al. Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma. Cancer. 2003;98(11):2385–92.CrossRef
8.
Lin SY, Chang KP, Hsieh MS, Ueng SH, Hao SP, Tseng CK, et al. The time frame of Epstein–Barr virus latent membrane protein-1 gene to disappear in nasopharyngeal swabs after initiation of primary radiotherapy is an independently significant prognostic factor predicting local control for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2005;63(5):1339–46.CrossRef
9.
Hao SP, Tsang NM, Chang KP. Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and epstein-barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma. Laryngoscope. 2004;114(11):2027–30.CrossRef
10.
Chang KP, Hao SP, Tsang NM, Ueng SH. Salvage surgery for locally recurrent nasopharyngeal carcinoma—a 10-year experience. Otolaryngol Head Neck Surg. 2004;131(4):497–502.CrossRef
11.
Hao SP, Tsang NM. Surgical management of recurrent nasopharyngeal carcinoma. Chang Gung Med J. 2010;33(4):361–9.PubMed
12.
Ng SH, Chang JT, Ko SF, Wan YL, Tang LM, Chen WC. MRI in recurrent nasopharyngeal carcinoma. Neuroradiology. 1999;41:855–62.CrossRef
13.
Ng SH, Liu HM, Ko SF, Hao SP, Chong VFH. Post treatment imaging of the nasopharynx. Eur J Radiol. 2002;44:82–95.CrossRef
14.
Hao SP, Tsang NM, Chang CN. Salvage surgery for recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2002;128(1):63–7.CrossRef
15.
Chen MK, Lai JC, Chang CC, Liu MT. Minimally invasive endoscopic nasopharyngectomy in the treatment of recurrent T1-2a nasopharyngeal carcinoma. Laryngoscope. 2007;117:894–6.CrossRef
16.
Endoscopic nasopharyngectomy. In: Ferris R, Myers EN ed. Operative otolaryngology: head and neck surgery, E-Book: 2-Volume Set;2017;32:271–6.
17.
Tsang RK, Holsinger FC. Transoral endoscopic nasopharyngectomy with a flexible next-generation robotic surgical system. Laryngoscope. 2016;126(10):2257–62.CrossRef
18.
Tsang RK, To VS, Ho AC, Ho WK, Chan JY, Wei WI. Early results of robotic assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma. Head Neck. 2015;37(6):788–93.CrossRef
19.
•• You R, Zou X, Hua Y-J, Han F, Li L, Zhao C, et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma—a case-matched comparison. Radiother Oncol. 2015;115:399–406 In this article, the authors report a matching study on 144 locally rNPC patients with limited local recurrence (rT1–3) who underwent either endoscopic nasopharyngectomy or re-irridiation. Compared with IMRT, endoscopic nasopharyngectomy was associated with a relatively better overall survival, quality of life, and significant decreases in post-treatment complications, and medical costs. The authors concluded that salvage endoscopic nasopharyngectomy may be more effective for maximizing survival and quality of life benefits and minimizing treatment-related complications and medical costs for limited rNPC patients, as compared with IMRT. CrossRef
20.
•• Leong YH, Soon YY, Lee KM, Wong LC, Tham IWK, Ho FCH. Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: a meta-analysis. Head Neck. 2017;40:622–31 In this meta-analysis on re-irradiation for rNPC, the authors report 41% 5-year OS, but was associated with pooled event rates of 72%. The recurrent T stage and tumor volume serve as the prognostic factors for OS in patients with rNPC who received salvage IMRT. CrossRef
21.
•• Liu Y-P, Lv X, Zou X. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma. Cancer Commun (Lond). 2019;29:2–11 This article reports endoscopic nasopharyngectomy in 10 fresh stage I NPC, in comparison with IMRT for 329 same stage patients, achieved a similar 5-year overall survival, local relapse-free survival, regional relapse-free survival, and distant metastasis-free survival. Endoscopic nasopharyngectomy was associated with lower medical costs, but better QOL scores than IMRT.
22.
Hao SP. Facial translocation approach to the skull base the viability of translocated facial bone graft. Otolaryngol Head Neck Surg. 2001;124:292–6.CrossRef
23.
Chen CW, Hao SP, Pan WL. Bone graft necrosis of facial translocation: comparison of 3 different techniques. Otolaryngol Head Neck Surg. 2006;135:719–23.CrossRef
24.
Hao SP. Modified facial translocation technique to prevent necrosis of bone graft. Laryngoscope. 2002;112:1691–5.CrossRef
25.
Wei WI, Ho CM, Yuen PW, Fung CF, Sham JS, Lam KH. Maxillary swing approach for resection of tumors in and around the nasopharynx. Arch Otolaryngol Head Neck Surg. 1995;121:638–42.CrossRef
26.
Chang KP, Tsang NM, Chen CY, Su JL, Hao SP. Endoscopic management of skull base osteoradionecrosis. Laryngoscope. 2000;110(7):1162–5.CrossRef
27.
Hao SP, Tsang NM, Chang KP, Hsu YS, Chen CK, Fang KH. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors. Acta Otolaryngol. 2008;128(4):473–81.CrossRef
28.
Wei WI, Chan JY, Ng RW, Ho WK. Surgical salvage of persistent or recurrent nasopharyngeal carcinoma with maxillary swing approach—critical appraisal after 2 decades. Head Neck. 2011;33(7):969–75.CrossRef
29.
Tian Y-M, Guan Y, Xiao W-W, Zeng L, Liu S, Lu T-X, et al. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma. Head Neck. 2015;38:225–31.CrossRef
30.
• Chan OSH, Sze HCK, Lee MCH, Chan LLK, Chang ATY, Lee SWM, et al. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma. Head Neck. 2016;39:533–40 In this article, the authors report that for rT3-4 NPC, adequate tumor dosage coverage was important, though complication could be high. The treatment related mortality was mainly vascular in nature. CrossRef
Metadaten
Titel
The Management of rNPC: Salvage Surgery vs. Re-irradiation
verfasst von
Chung-Yu Hao
Sheng-Po Hao
Publikationsdatum
01.09.2020
Verlag
Springer US
Erschienen in
Current Oncology Reports / Ausgabe 9/2020
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-020-00949-0

Weitere Artikel der Ausgabe 9/2020

Current Oncology Reports 9/2020 Zur Ausgabe

Head and Neck Cancers (EY Hanna, Section Editor)

Radiation Therapy and Mandibular Osteoradionecrosis: State of the Art

Gastrointestinal Cancers (J Meyer, Section Editor)

Immunotherapy in Anal Cancer

Cardio-oncology (EH Yang, Section Editor)

Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease

Correction

Correction to: The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population

Head and Neck Cancers (EY Hanna, Section Editor)

Value and Quality of Care in Head and Neck Oncology

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Racial Disparity in Response to Prostate Cancer Systemic Therapies

Neu im Fachgebiet Onkologie

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise